3864 results for «660»
3864 results
Paclitaxel and sirolimus coated balloons: create evidence before claims
20 May 2021 – From EuroPCR 2021
Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...
Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme
20 May 2021 – From EuroPCR 2021
Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
Coronary access after TAVI, a growing need
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...
Redefining hypertension management with renal denervation
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma, David Kandzari, Felix Mahfoud and Andrew Sharp in order to understand the latest data on the safety and efficacy of radiofrequency renal denervation including future studies, to learn about the long-term durability of renal denervation in a real-world patient population, and...
Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease
20 May 2021 – From EuroPCR 2021
Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
Sustained Limus release, redefining indications for drug-eluting balloons
20 May 2021 – From EuroPCR 2021
Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...
EAPCI-PCR Fellows Course 2021 - Coronary track: Revascularisation strategy/Left main disease
14 Apr 2021 – From EuroPCR 2021
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at the beginning of their careers. Education and networking are at the core of the building of future careers powered by...
EAPCI-PCR Fellows Course 2021 - Coronary track: Ambiguous LM/PCI strategy for mid-LAD bifurcation
14 Apr 2021 – From EuroPCR 2021
The best PCI strategies for an ambiguous LM, then a mid-LAD bifurcation. With golden tips from G. Stankovic and T. Lefèvre!
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at...
PCR Clinical Research 2021 - Waiting for EBC-MAIN, a randomised trial of stenting strategies for the treatment of LM coronary bifurcation disease
28 Apr 2021 – From EuroPCR 2021
How are you going to treat your next left main lesion involving both LAD and CX ostia: provisional vs. upfront two-stent strategy ? Follow this PCR Clinical Research episode for more news on the EBC MAIN trial!
PCR Clinical Research - Late breaking science at EuroPCR 2021:...
PCR Peripheral for beginners - Femoro popliteal angioplasty
Watch this episode if you want to:
- Know where we are regarding paclitataxel controversy,
- Know how to deal with simple superficial artery case angioplasty,
- Discuss when to perform controlateral and antegrade accesses,
- Learn when to go intra luminal or sub intimal,
- Know how to select the best tools to use...
EuroPCR 2021 Clinical Research - Waiting for FUTURE II, a randomised trial of a novel, thin-strut bioresorbable scaffold
14 Apr 2021 – From EuroPCR 2021
Will thinner struts breathe new life into the bioresorbable scaffolds ? Follow this PCR Clinical Research episode to find out more about the latest BRS technology!
PCR Clinical Research - Late breaking science at EuroPCR 2021: appraising the methods, while awaiting the results.
EuroPCR 2021 - Innovations in stable CAD
18 May 2021 – From EuroPCR 2021
In this session, consider the accuracy of OFR in assessing stenting result and residual disease, appraise a novel hybrid IVUS-OCT catheter system, and question whether NOCAD/INOCA patients could be diagnosed with a new physiological wire by obtaining pressure-derived CFR.
EuroPCR 2021 - Innovations in mitral valve replacement and repair
18 May 2021 – From EuroPCR 2021
In this session, get a clear presentation of the SATURN device, its procedure and its early results, and a good demonstration of the successful transseptal deployment of this implant in the acute porcine model.
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
